𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The Quantitative Prediction of CYP-mediated Drug Interaction by Physiologically Based Pharmacokinetic Modeling

✍ Scribed by Motohiro Kato; Yoshihisa Shitara; Hitoshi Sato; Kunihiro Yoshisue; Masaru Hirano; Toshihiko Ikeda; Yuichi Sugiyama

Publisher
Springer US
Year
2008
Tongue
English
Weight
210 KB
Volume
25
Category
Article
ISSN
0724-8741

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prediction of pharmacokinetics prior to
Prediction of pharmacokinetics prior to In Vivo studies. II. Generic physiologically based pharmacokinetic models of drug disposition
✍ Patrick Poulin; Frank-Peter Theil 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB

Many in vitro data on physicochemical properties and specific absorption, distribution, metabolism, and elimination (ADME) processes are already available at early stages of drug discovery. These data about new drug candidates could be integrated/ connected in physiologically based pharmacokinetic (

Utility of a physiologically–based pharm
Utility of a physiologically–based pharmacokinetic (PBPK) modeling approach to quantitatively predict a complex drug–drug–disease interaction scenario for rivaroxaban during the drug review process: implications for clinical practice
✍ Joseph A. Grillo; Ping Zhao; Julie Bullock; Brian P. Booth; Min Lu; Kathy Robie- 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 535 KB

Background: Rivaroxaban is an oral Factor Xa inhibitor. The primary objective of this communication was to quantitatively predict changes in rivaroxaban exposure when individuals with varying degrees of renal impairment are co-administered with another drug that is both a P-gp and a moderate CYP3A4

Prediction of the disposition of midazol
Prediction of the disposition of midazolam in surgical patients by a physiologically based pharmacokinetic model
✍ Sven Björkman; D. Russell Wada; Britt-Marie Berling; Göran Benoni 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 243 KB

The aim of this study was to predict the disposition of midazolam in individual surgical patients by physiologically based pharmacokinetic (PBPK) modeling and explore the causes of interindividual variability. Tissue±plasma partition coef®cients (k p ) were scaled from rat to human values by a physi